Literature DB >> 19073650

Thiazolidinediones: do harms outweigh benefits?

Lorraine L Lipscombe1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19073650      PMCID: PMC2612067          DOI: 10.1503/cmaj.081713

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

Review 1.  Thiazolidinediones.

Authors:  Hannele Yki-Järvinen
Journal:  N Engl J Med       Date:  2004-09-09       Impact factor: 91.245

2.  Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.

Authors:  Sonal Singh; Yoon K Loke; Curt D Furberg
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272

3.  Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

Authors:  John A Dormandy; Bernard Charbonnel; David J A Eckland; Erland Erdmann; Massimo Massi-Benedetti; Ian K Moules; Allan M Skene; Meng H Tan; Pierre J Lefèbvre; Gordon D Murray; Eberhard Standl; Robert G Wilcox; Lars Wilhelmsen; John Betteridge; Kåre Birkeland; Alain Golay; Robert J Heine; László Korányi; Markku Laakso; Marián Mokán; Antanas Norkus; Valdis Pirags; Toomas Podar; André Scheen; Werner Scherbaum; Guntram Schernthaner; Ole Schmitz; Jan Skrha; Ulf Smith; Jan Taton
Journal:  Lancet       Date:  2005-10-08       Impact factor: 79.321

4.  Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis.

Authors:  Yoon K Loke; Sonal Singh; Curt D Furberg
Journal:  CMAJ       Date:  2008-12-10       Impact factor: 8.262

5.  Thiazolidinediones and cardiovascular outcomes in older patients with diabetes.

Authors:  Lorraine L Lipscombe; Tara Gomes; Linda E Lévesque; Janet E Hux; David N Juurlink; David A Alter
Journal:  JAMA       Date:  2007-12-12       Impact factor: 56.272

6.  Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

Authors:  Steven E Nissen; Kathy Wolski
Journal:  N Engl J Med       Date:  2007-05-21       Impact factor: 91.245

Review 7.  Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials.

Authors:  Rodrigo M Lago; Premranjan P Singh; Richard W Nesto
Journal:  Lancet       Date:  2007-09-29       Impact factor: 79.321

8.  Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.

Authors:  A Michael Lincoff; Kathy Wolski; Stephen J Nicholls; Steven E Nissen
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272

  8 in total
  9 in total

1.  Thiazolidinedione use and the risk of fractures.

Authors:  Tjark Reblin
Journal:  CMAJ       Date:  2009-04-14       Impact factor: 8.262

Review 2.  Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?

Authors:  Elizabeth M Haney; Stuart J Warden; M Michael Bliziotes
Journal:  Bone       Date:  2009-08-05       Impact factor: 4.398

Review 3.  Alogliptin: a review of its use in the management of type 2 diabetes mellitus.

Authors:  Lesley J Scott
Journal:  Drugs       Date:  2010-10-22       Impact factor: 9.546

4.  Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction.

Authors:  Ling Tao; Yajing Wang; Erhe Gao; Hangxiang Zhang; Yuexing Yuan; Wayne B Lau; Lawrence Chan; Walter J Koch; Xin L Ma
Journal:  Circ Res       Date:  2009-11-25       Impact factor: 17.367

Review 5.  Complementary and alternative medicine for the treatment of type 2 diabetes.

Authors:  Richard Nahas; Matthew Moher
Journal:  Can Fam Physician       Date:  2009-06       Impact factor: 3.275

6.  Double-blind, placebo-controlled clinical evaluation of an Ayurvedic formulation (GlucoCare capsules) in non-insulin dependent diabetes mellitus.

Authors:  R K Sharma; Pralhad S Patki
Journal:  J Ayurveda Integr Med       Date:  2010-01

Review 7.  Safety and efficacy of rosiglitazone in the elderly diabetic patient.

Authors:  Adie Viljoen; Alan Sinclair
Journal:  Vasc Health Risk Manag       Date:  2009

8.  Prescription pattern of chinese herbal products for diabetes mellitus in taiwan: a population-based study.

Authors:  Chung-Yu Huang; Yueh-Ting Tsai; Jung-Nien Lai; Feng-Lin Hsu
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-17       Impact factor: 2.629

9.  Clustering of the metabolic syndrome components in adolescence: role of visceral fat.

Authors:  Melkaye G Melka; Michal Abrahamowicz; Gabriel T Leonard; Michel Perron; Louis Richer; Suzanne Veillette; Daniel Gaudet; Tomáš Paus; Zdenka Pausova
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.